RAD-140 10 mg Magnus Pharmaceuticals

RAD-140 10 mg Magnus Pharmaceuticals – instructions for use

RAD-140 10 mg Magnus Pharmaceuticals is a SARM with an extremely potent anabolic effect and a preventive mechanism of action. The drug can reduce androgenic side effects of testosterone, such as prostate enlargement, testicular shrinkage, acne, oily skin and inflammation of breast tissue.

What are the effects of RAD-140 10 mg Magnus Pharmaceuticals?

The effect of RAD-140 10 mg Magnus Pharmaceuticals is well known among athletes and bodybuilders. The drug actively affects muscle mass and activates its rapid growth, provided that you consume a good amount of protein and actively train with a lot of weight.

According to studies and reviews, during the course there is an improvement in the reaction and an increase in endurance. This allows you to devote yourself completely to the training process, which contributes to enormous success in sports. RAD-140 10 mg Magnus Pharmaceuticals does not reduce muscle mass during the active phase of weight loss.

Side effects and contraindications to take

RAD-140 is non-toxic and harmless. But with the wrong dosage, there may be minor changes in the body, such as:

• pain in the chest area;
• dyspnoea;
• acne
• constipation.

Before use, a medical consultation is essential! The drug is contraindicated in minors and people with various types of cancer. Do not recommend it to people who are allergic to the active ingredients of the drug.

RAD-140 10 mg Magnus Pharmaceuticals Dosage schedule and how to take it

The daily dosage can be of two types:

• if the weight does not exceed 80 kilograms, the norm per day is 10 milligrams with a duration of use of 6 to 12 weeks;
• if the weight is more than 80 kilograms, the daily norm is 20 milligrams with a duration of use of 8-12 weeks.

To increase muscle mass, you should increase your daily protein intake (at least 3 grams per 1 kilogram of body weight), consume enough calories and also do intense training with heavy weights.

List of references

1. Miller CP, Shomali M, Lyttle CR, et al. Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140. ACS Med Chem Lett. 2011;2(2):124-129.
2. Basaria S, Collins L, Dillon EL, et al. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci. 2013;68(1):87-95.
3. Hanada K, Furuya K, Yamamoto N, Nejishima H, Ichikawa K, Nakamura T. Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis. Biol Pharm Bull. 2003;26(11):1563-1569.
4. Yarrow JF, Conover CF, McCoy SC, et al. 17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate. Am J Physiol Endocrinol Metab. 2011;300(4):E650-60.
5. Miller CP, Shomali M, Lyttle CR, et al. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology. 2011;152(2):351-361.